References
- Sun JR, Kim SM, Seo MH, Kim MJ, Lee JH, Myoung H. Oral cancer incidence based on annual cancer statistics in Korea. J Korean Assoc Oral Maxillofac Surg 2012;38:20-8. https://doi.org/10.5125/jkaoms.2012.38.1.20
- Franceschi D, Gupta R, Spiro RH, Shah JP. Improved survival in the treatment of squamous carcinoma of the oral tongue. Am J Surg 1993;166:360-5. https://doi.org/10.1016/S0002-9610(05)80333-2
- Kirita T, Okabe S, Izumo T, Sugimura M. Risk factors for the postoperative local recurrence of tongue carcinoma. J Oral Maxillofac Surg 1994;52:149-54. https://doi.org/10.1016/0278-2391(94)90398-0
- Sarkaria JN, Harari PM. Oral tongue cancer in young adults less than 40 years of age: rationale for aggressive therapy. Head Neck 1994;16:107-11. https://doi.org/10.1002/hed.2880160202
- Silverman S Jr, Gorsky M, Lozada F. Oral leukoplakia and malignant transformation. A follow-up study of 257 patients. Cancer 1984;53:563-8. https://doi.org/10.1002/1097-0142(19840201)53:3<563::AID-CNCR2820530332>3.0.CO;2-F
- Banoczy J. Follow-up studies in oral leukoplakia. J Maxillofac Surg 1977;5:69-75. https://doi.org/10.1016/S0301-0503(77)80079-9
- Saito T, Sugiura C, Hirai A, et al. Development of squamous cell carcinoma from pre-existent oral leukoplakia: with respect to treatment modality. Int J Oral Maxillofac Surg 2001;30:49-53. https://doi.org/10.1054/ijom.2000.0012
- Schepman KP, van der Meij EH, Smeele LE, van der Waal I. Malignant transformation of oral leukoplakia: a follow-up study of a hospital-based population of 166 patients with oral leukoplakia from The Netherlands. Oral Oncol 1998;34: 270-5. https://doi.org/10.1016/S1368-8375(98)80007-9
- Yang SW, Tsai CN, Lee YS, Chen TA. Treatment outcome of dysplastic oral leukoplakia with carbon dioxide laser--emphasis on the factors affecting recurrence. J Oral Maxillofac Surg 2011;69:e78-87.
- Frame JW. The management of oral premalignant lesions. Br J Oral Maxillofac Surg 1992;30:71. https://doi.org/10.1016/0266-4356(92)90072-Q
- Pignon JP, Bourhis J, Domenge C, Designe L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet 2000;355:949-55. https://doi.org/10.1016/S0140-6736(00)90011-4
- Po Wing Yuen A, Lam KY, Lam LK, et al. Prognostic factors of clinically stage I and II oral tongue carcinoma-A comparative study of stage, thickness, shape, growth pattern, invasive front malignancy grading, Martinez-Gimeno score, and pathologic features. Head Neck 2002;24:513-20. https://doi.org/10.1002/hed.10094
- Spiro RH, Huvos AG, Wong GY, Spiro JD, Gnecco CA, Strong EW. Predictive value of tumor thickness in squamous carcinoma confined to the tongue and floor of the mouth. Am J Surg 1986;152:345-50. https://doi.org/10.1016/0002-9610(86)90302-8
- Asakage T, Yokose T, Mukai K, et al. Tumor thickness predicts cervical metastasis in patients with stage I/II carcinoma of the tongue. Cancer 1998;82:1443-8. https://doi.org/10.1002/(SICI)1097-0142(19980415)82:8<1443::AID-CNCR2>3.0.CO;2-A
- Kaya S, Yilmaz T, Gürsel B, Sarac S, Sennaroglu L. The value of elective neck dissection in treatment of cancer of the tongue. Am J Otolaryngol 2001;22:59-64. https://doi.org/10.1053/ajot.2001.20681
- Mashberg A. Tolonium (toluidine blue) rinse--a screening method for recognition of squamous carcinoma. Continuing study of oral cancer IV. JAMA 1981;245:2408-10. https://doi.org/10.1001/jama.1981.03310480024019
- Iwai H, Kyomoto R, Ha-Kawa SK, Lee S, Yamashita T. Magnetic resonance determination of tumor thickness as predictive factor of cervical metastasis in oral tongue carcinoma. Laryngoscope 2002;112:457-61. https://doi.org/10.1097/00005537-200203000-00010
- Preda L, Chiesa F, Calabrese L, et al. Relationship between histologic thickness of tongue carcinoma and thickness estimated from preoperative MRI. Eur Radiol 2006;16:2242-8. https://doi.org/10.1007/s00330-006-0263-9
- Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium. Clinical implications of multicentric origin. Cancer 1953;6:963-8. https://doi.org/10.1002/1097-0142(195309)6:5<963::AID-CNCR2820060515>3.0.CO;2-Q
- Tabor MP, Brakenhoff RH, van Houten VM, et al. Persistence of genetically altered fields in head and neck cancer patients: biological and clinical implications. Clin Cancer Res 2001;7: 1523-32.